These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

708 related items for PubMed ID: 16982097

  • 1. Collagen and major histocompatibility class II expression in mesenchymal cells from CIITA hypomorphic mice.
    Xu Y, McDonald J, Perloff E, Butticè G, Schreiber BM, Smith BD.
    Mol Immunol; 2007 Mar; 44(7):1709-21. PubMed ID: 16982097
    [Abstract] [Full Text] [Related]

  • 2. IL-1 beta inhibits IFN-gamma-induced class II MHC expression by suppressing transcription of the class II transactivator gene.
    Rohn W, Tang LP, Dong Y, Benveniste EN.
    J Immunol; 1999 Jan 15; 162(2):886-96. PubMed ID: 9916712
    [Abstract] [Full Text] [Related]

  • 3. IFN-gamma regulation of the type IV class II transactivator promoter in astrocytes.
    Dong Y, Rohn WM, Benveniste EN.
    J Immunol; 1999 Apr 15; 162(8):4731-9. PubMed ID: 10202014
    [Abstract] [Full Text] [Related]

  • 4. Major histocompatibility class II transactivator (CIITA) mediates repression of collagen (COL1A2) transcription by interferon gamma (IFN-gamma).
    Xu Y, Wang L, Butticè G, Sengupta PK, Smith BD.
    J Biol Chem; 2004 Oct 01; 279(40):41319-32. PubMed ID: 15247294
    [Abstract] [Full Text] [Related]

  • 5. Class II transactivator-mediated regulation of major histocompatibility complex class II antigen expression is important for hematopoietic progenitor cell suppression by chemokines and iron-binding proteins.
    Broxmeyer HE, Cooper S, Hangoc G, Chang CH.
    Exp Hematol; 2006 Aug 01; 34(8):1078-84. PubMed ID: 16863914
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Varying functions of specific major histocompatibility class II transactivator promoter III and IV elements in melanoma cell lines.
    Goodwin BL, Xi H, Tejiram R, Eason DD, Ghosh N, Wright KL, Nagarajan U, Boss JM, Blanck G.
    Cell Growth Differ; 2001 Jun 01; 12(6):327-35. PubMed ID: 11432807
    [Abstract] [Full Text] [Related]

  • 8. Reduced IL-4-, lipopolysaccharide-, and IFN-gamma-induced MHC class II expression in mice lacking class II transactivator due to targeted deletion of the GTP-binding domain.
    Itoh-Lindstrom Y, Piskurich JF, Felix NJ, Wang Y, Brickey WJ, Platt JL, Koller BH, Ting JP.
    J Immunol; 1999 Sep 01; 163(5):2425-31. PubMed ID: 10452977
    [Abstract] [Full Text] [Related]

  • 9. TNF-alpha suppresses IFN-gamma-induced MHC class II expression in HT1080 cells by destabilizing class II trans-activator mRNA.
    Han Y, Zhou ZH, Ransohoff RM.
    J Immunol; 1999 Aug 01; 163(3):1435-40. PubMed ID: 10415044
    [Abstract] [Full Text] [Related]

  • 10. Down-regulation of MHC class II expression through inhibition of CIITA transcription by lytic transactivator Zta during Epstein-Barr virus reactivation.
    Li D, Qian L, Chen C, Shi M, Yu M, Hu M, Song L, Shen B, Guo N.
    J Immunol; 2009 Feb 15; 182(4):1799-809. PubMed ID: 19201831
    [Abstract] [Full Text] [Related]

  • 11. A CIITA-independent pathway that promotes expression of endogenous rather than exogenous peptides in immune-privileged sites.
    Arancibia-Cárcamo CV, Osawa H, Arnett HA, Háskova Z, George AJ, Ono SJ, Ting JP, Streilein JW.
    Eur J Immunol; 2004 Feb 15; 34(2):471-80. PubMed ID: 14768052
    [Abstract] [Full Text] [Related]

  • 12. Interferon-gamma induces major histocompatibility class II transactivator (CIITA), which mediates collagen repression and major histocompatibility class II activation by human aortic smooth muscle cells.
    Butticè G, Miller J, Wang L, Smith BD.
    Circ Res; 2006 Mar 03; 98(4):472-9. PubMed ID: 16439692
    [Abstract] [Full Text] [Related]

  • 13. Different levels of control prevent interferon-gamma-inducible HLA-class II expression in human neuroblastoma cells.
    Croce M, De Ambrosis A, Corrias MV, Pistoia V, Occhino M, Meazza R, Giron-Michel J, Azzarone B, Accolla RS, Ferrini S.
    Oncogene; 2003 Oct 30; 22(49):7848-57. PubMed ID: 14586411
    [Abstract] [Full Text] [Related]

  • 14. Identification of distinct regions of 5' flanking DNA that mediate constitutive, IFN-gamma, STAT1, and TGF-beta-regulated expression of the class II transactivator gene.
    Piskurich JF, Wang Y, Linhoff MW, White LC, Ting JP.
    J Immunol; 1998 Jan 01; 160(1):233-40. PubMed ID: 9551976
    [Abstract] [Full Text] [Related]

  • 15. Attenuation of MHC class II expression in macrophages infected with Mycobacterium bovis bacillus Calmette-Guérin involves class II transactivator and depends on the Nramp1 gene.
    Wojciechowski W, DeSanctis J, Skamene E, Radzioch D.
    J Immunol; 1999 Sep 01; 163(5):2688-96. PubMed ID: 10453010
    [Abstract] [Full Text] [Related]

  • 16. Regulation of MHC class II expression in glioma cells by class II transactivator (CIITA).
    Takamura Y, Ikeda H, Kanaseki T, Toyota M, Tokino T, Imai K, Houkin K, Sato N.
    Glia; 2004 Mar 01; 45(4):392-405. PubMed ID: 14966870
    [Abstract] [Full Text] [Related]

  • 17. Epigenetic silencing of the CIITA gene and posttranscriptional regulation of class II MHC genes in ocular melanoma cells.
    Radosevich M, Song Z, Gorga JC, Ksander B, Ono SJ.
    Invest Ophthalmol Vis Sci; 2004 Sep 01; 45(9):3185-95. PubMed ID: 15326139
    [Abstract] [Full Text] [Related]

  • 18. HDAC2 deacetylates class II transactivator and suppresses its activity in macrophages and smooth muscle cells.
    Kong X, Fang M, Li P, Fang F, Xu Y.
    J Mol Cell Cardiol; 2009 Mar 01; 46(3):292-9. PubMed ID: 19041327
    [Abstract] [Full Text] [Related]

  • 19. Stat1 alpha expression is involved in IFN-gamma induction of the class II transactivator and class II MHC genes.
    Lee YJ, Benveniste EN.
    J Immunol; 1996 Aug 15; 157(4):1559-68. PubMed ID: 8759739
    [Abstract] [Full Text] [Related]

  • 20. MHC class II antigen presentation pathway in murine tumours: tumour evasion from immunosurveillance?
    Walter W, Lingnau K, Schmitt E, Loos M, Maeurer MJ.
    Br J Cancer; 2000 Nov 15; 83(9):1192-201. PubMed ID: 11027433
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 36.